COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC:

Get the latest research information from NIH: Menu
Trial record 1 of 1 for:    NCT01883076
Previous Study | Return to List | Next Study

Safety Study of Autologous Umbilical Cord Blood Cells for Treatment of Hypoplastic Left Heart Syndrome

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01883076
Recruitment Status : Active, not recruiting
First Posted : June 21, 2013
Last Update Posted : December 23, 2019
University of Oklahoma
Children's Hospital of Philadelphia
Children's Hospitals and Clinics of Minnesota
Children's Hospital Los Angeles
Children's Hospital Colorado
Mayo Clinic
Information provided by (Responsible Party):
Timothy J Nelson, MD, PhD, ReGen Theranostics, Inc.

No Study Results Posted on for this Study
Recruitment Status : Active, not recruiting
Estimated Primary Completion Date : November 2020
Estimated Study Completion Date : May 2021